The international surgical journal with global reach

Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial. Gut 2019; 68: 1774-1780

Published: 20th March 2020

Authors: De Groof EJ, Stevens TW, Eshuis EJ, Gardenbroek TJ, Bosmans JE, van Dongen JM et al.

Conclusion

Some 143 patients who still had symptoms after three months of conventional treatment were randomized. After one year, healthcare costs were lower in the group that had surgery: mean difference -8931 euros, 95 per cent c.i. -12087 to -5097 euros.

Pubmed Link